Y Intercept (Hong Kong) LTD Eledon Pharmaceuticals, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $1.37 Billion
- Q1 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 12,065 shares of ELDN stock, worth $39,693. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,065Holding current value
$39,693% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ELDN
# of Institutions
78Shares Held
37.3MCall Options Held
17KPut Options Held
2.7K-
Bvf Inc San Francisco, CA6.29MShares$20.7 Million0.96% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$11.7 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$9.72 Million0.0% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.55MShares$8.39 Million2.15% of portfolio
-
First Light Asset Management, LLC Edina, MN2.33MShares$7.66 Million0.93% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $45.3M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...